Zhejiang Xianju Pharmaceutical Co Ltd

SHE:002332 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.23 Billion
CN¥9.01 Billion CNY
Market Cap Rank
#7477 Global
#1273 in China
Share Price
CN¥9.11
Change (1 day)
-0.11%
52-Week Range
CN¥8.97 - CN¥11.58
All Time High
CN¥16.51
About

Zhejiang Xianju Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progestero… Read more

Zhejiang Xianju Pharmaceutical Co Ltd (002332) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.022x

Based on the latest financial reports, Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a cash flow conversion efficiency ratio of 0.022x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥130.05 Million) by net assets (CN¥6.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Xianju Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Zhejiang Xianju Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Zhejiang Xianju Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Xianju Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥5.89 Billion CN¥398.66 Million 0.068x -33.71%
2023-12-31 CN¥5.83 Billion CN¥595.48 Million 0.102x -7.67%
2022-12-31 CN¥5.51 Billion CN¥609.28 Million 0.111x -19.09%
2021-12-31 CN¥4.94 Billion CN¥676.15 Million 0.137x -20.61%
2020-12-31 CN¥4.58 Billion CN¥789.23 Million 0.172x +1.34%
2019-12-31 CN¥3.06 Billion CN¥519.81 Million 0.170x +138.33%
2018-12-31 CN¥2.71 Billion CN¥193.27 Million 0.071x +1.60%
2017-12-31 CN¥2.39 Billion CN¥167.47 Million 0.070x +0.71%
2016-12-31 CN¥2.24 Billion CN¥155.91 Million 0.070x -24.84%
2015-12-31 CN¥2.15 Billion CN¥199.61 Million 0.093x -19.61%
2014-12-31 CN¥1.23 Billion CN¥141.64 Million 0.115x +114.84%
2013-12-31 CN¥1.18 Billion CN¥63.46 Million 0.054x +93.15%
2012-12-31 CN¥1.20 Billion CN¥33.43 Million 0.028x -78.28%
2011-12-31 CN¥1.15 Billion CN¥147.63 Million 0.128x -7.59%
2010-12-31 CN¥1.12 Billion CN¥155.29 Million 0.138x +45.55%
2009-12-31 CN¥1.10 Billion CN¥104.68 Million 0.095x +7.10%
2008-12-31 CN¥405.55 Million CN¥36.03 Million 0.089x -63.11%
2007-12-31 CN¥400.83 Million CN¥96.53 Million 0.241x +77.49%
2006-12-31 CN¥390.97 Million CN¥53.05 Million 0.136x --